Familial amyloidosis: Difference between revisions
No edit summary |
No edit summary |
||
(3 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Familial amyloidosis}} | {{Familial amyloidosis}} | ||
'''For patient information, click [[Familial amyloidosis (patient information)|here]]''' | '''For patient information, click [[Familial amyloidosis (patient information)|here]]'''<br> | ||
'''To go back to the Amyloidosis landing page, click [[Amyloidosis|here]].'''<br> | |||
{{CMG}}; {{AE}}{{Fs}} | {{CMG}}; {{AE}}{{Fs}} | ||
Line 10: | Line 10: | ||
==[[Familial amyloidosis historical perspective|Historical Perspective]]== | ==[[Familial amyloidosis historical perspective|Historical Perspective]]== | ||
==[[Familial amyloidosis classification|Classification]]== | ==[[Familial amyloidosis classification|Classification]]== | ||
==[[Familial amyloidosis pathophysiology|Pathophysiology]]== | ==[[Familial amyloidosis pathophysiology|Pathophysiology]]== | ||
==[[Familial amyloidosis causes|Causes]]== | ==[[Familial amyloidosis causes|Causes]]== | ||
==[[Familial amyloidosis differential diagnosis|Differentiating Familial amyloidosis from other Diseases]]== | ==[[Familial amyloidosis differential diagnosis|Differentiating Familial amyloidosis from other Diseases]]== | ||
==[[Familial amyloidosis epidemiology and demographics|Epidemiology and Demographics]]== | ==[[Familial amyloidosis epidemiology and demographics|Epidemiology and Demographics]]== | ||
==[[Familial amyloidosis risk factors|Risk Factors]]== | ==[[Familial amyloidosis risk factors|Risk Factors]]== | ||
==[[Familial amyloidosis screening|Screening]]== | ==[[Familial amyloidosis screening|Screening]]== | ||
==[[Familial amyloidosis natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | ==[[Familial amyloidosis natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | ||
Line 37: | Line 25: | ||
==Treatment== | ==Treatment== | ||
[[Familial amyloidosis medical therapy|Medical Therapy | [[Familial amyloidosis medical therapy|Medical Therapy]] | [[Familial amyloidosis surgery|Surgery]] | [[Familial amyloidosis primary prevention|Primary Prevention]] | [[Familial amyloidosis secondary prevention|Secondary Prevention]] | [[Familial amyloidosis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Familial amyloidosis future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== |
Latest revision as of 15:32, 10 February 2020
Familial amyloidosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Familial amyloidosis On the Web |
American Roentgen Ray Society Images of Familial amyloidosis |
For patient information, click here
To go back to the Amyloidosis landing page, click here.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.
Synonyms and keywords:
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Familial amyloidosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic study of choice | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X-Ray Findings | Echocardiography and Ultrasound | CT-Scan Findings | MRI Findings | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies